The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Amazon.com Inc COM 023135106 217,366 912 SH SOLE 0 912 0 0
Fate Therapeutics Inc COM 31189P102 27,000 10,000 SH SOLE 0 10,000 0 0
GAMCO Global Gold, Natural Resources & Income Trust COM SH BEN INT 36465A109 115,207 23,803 SH SOLE 0 23,803 0 0
GAMCO Natural Resources Gold & Income Trust SH BEN INT 36465E101 164,728 20,212 SH SOLE 0 20,212 0 0
Immunome Inc COM 45257U108 224,339 10,587 SH SOLE 0 10,587 0 0
iShares MSCI USA Quality Factor ETF MSCI USA QLT FCT 46432F339 426,320 1,943 SH SOLE 0 1,942 0 0
Morgan Stanley Emerging Markets Domestic Debt Fund, Inc COM 617477104 138,239 23,510 SH SOLE 0 23,510 0 0
Saba Capital Income & Opportunities Fund II COM 880198205 102,288 12,250 SH SOLE 0 12,250 0 0
Schwab US Large-Cap ETF US LRG CAP ETF 808524201 967,991 32,891 SH SOLE 0 32,891 0 0
Templeton Emerging Markets Income Fund COM 880192109 124,690 18,500 SH SOLE 0 18,500 0 0
Vanguard Growth Index Fund ETF Shares MRNGSTR GRWT ETF 922908736 265,656 3,084 SH SOLE 0 3,084 0 0
Zentalis Pharmaceuticals Inc COM 98943L107 417,182 86,017 SH SOLE 0 86,017 0 0